New research could help improve the effectiveness of immunotherapy for people with brain tumors

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread to the brain from other parts of the body respond to immunotherapy while glioblastoma, an aggressive cancer that originates in the brain, does not.

Related Keywords

Eileen Shiuan ,Willy Hugo ,Jiyoon Kim ,Amber Monteleone ,Jenny Kienzler ,Lily Ramsey ,Geoffrey Owens ,David Nathanson ,Timothy Cloughesy ,Robert Prins ,Alexander Lee ,Alu Sun ,Jeremy Reynoso ,Shanpeng Li ,Richard Everson ,Jonsson Cancer Center ,Jonsson Comprehensive Cancer Center ,Geffen School Of Medicine ,Parker Institute For Cancer Immunotherapy ,National Cancer Institute ,Cancer Research Institute ,David Geffen School Of Medicine ,National Institutes Of Health Center ,Comprehensive Cancer Center ,Clinical Investigation ,David Geffen School ,Geffen School ,Kwon Kim ,Jonsson Cancer ,Lizhong Ding ,Linda Liau ,National Institutes ,Health Specialized Programs ,Research Excellence ,Brain Cancer ,Health National Center ,Advancing Translational Science ,Parker Institute ,Brain Tumor Funder ,Cancer Research ,Brain ,Immunotherapy ,Brain Metastases ,Dancer ,Fell ,Glioblastoma ,Lymph Nodes ,Medicine ,Melanoma ,Neurosurgery ,Research ,Humor ,